Program #845 • Available Tuesday, January 17, 2006
Certified for AMA PRA Category 1 Credits™ through Saturday, January 17, 2009

Alzheimer's Disease: Clearing Up Confusion

 

Program Description

Alzheimer’s disease (AD), the most common form of dementia, is a fatal, progressive neurodegenerative disorder. However, early detection and intervention can help mitigate the patient’s deterioration and ease the strain that AD places on the patient’s family and caregivers. In this program, Dr. Lombard offers insights into early detection and clinical evaluation of patients with AD, including interpretation of imaging studies. He also reviews current treatment strategies and discusses supportive care. The program concludes with a case presentation, in which Dr. Lombard interviews an actual patient with AD.

(60 minutes)

Credit Information

Up to 2 AMA PRA Category 1 Credits™

This activity is designed for primary care physicians and other healthcare professionals who are interested in the diagnosis and treatment of Alzheimer’s disease.

Learning Objectives

After taking part in this CME activity, participants should be able to:

CME Credit Designations

ACCME The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA NCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP This activity has been reviewed and is acceptable for up to 2 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins Wednesday, January 17, 2007. Term of approval is for one year from this date, with option for yearly renewal.

AOA This activity is eligible for up to 2 hours of credit in Category 2-A of the American Osteopathic Association.